Colla boration AgreementColla Boration Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
Contract Type FiledFebruary 14th, 2014 Company IndustryThe Company and NCC wish to collaborate regarding a clinical Named patient Use program conducted in Singapore at NCC with the dendritic cell vaccine MelCancerVac® belonging to the Company. The program is further defined in Appendix A hereto and shall hereinafter be referred to as the “NpU program”.